Jeffrey Stein - Dec 29, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Jeffrey Stein
Stock symbol
CDTX
Transactions as of
Dec 29, 2021
Transactions value $
$0
Form type
4
Date filed
1/7/2022, 07:24 PM
Previous filing
Nov 15, 2021
Next filing
Feb 18, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Options Exercise $0 +20K +4.26% $0.00 490K Dec 29, 2021 Direct F1, F2
holding CDTX Common Stock 232K Dec 29, 2021 By trust
holding CDTX Common Stock 42K Dec 29, 2021 By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Restricted Stock Unit Options Exercise $0 -20K -50% $0.00 20K Dec 29, 2021 Common Stock 20K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
F3 Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
F4 On January 31, 2019, the Reporting Person was granted restricted stock units totaling 60,000 shares subject to vesting upon the achievement of various milestones.